Getein Biotech, Inc (603387.SS)
CNY 8.59
(-0.12%)
CNY 8.59
(-0.12%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.36 Billion CNY | -24.85% |
| 2022 | 1.82 Billion CNY | 29.97% |
| 2021 | 1.4 Billion CNY | 24.78% |
| 2020 | 1.12 Billion CNY | 16.02% |
| 2019 | 968.2 Million CNY | 41.09% |
| 2018 | 686.23 Million CNY | 40.45% |
| 2017 | 488.58 Million CNY | 32.37% |
| 2016 | 369.09 Million CNY | 33.53% |
| 2015 | 276.42 Million CNY | 31.45% |
| 2014 | 210.29 Million CNY | 36.38% |
| 2013 | 154.19 Million CNY | 109.39% |
| 2012 | 73.64 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 259.34 Million CNY | -11.46% |
| 2024 Q1 | 321.58 Million CNY | -12.66% |
| 2024 Q2 | 296.08 Million CNY | -7.93% |
| 2023 FY | 1.36 Billion CNY | -24.85% |
| 2023 Q3 | 297.6 Million CNY | -6.72% |
| 2023 Q4 | 368.2 Million CNY | 23.72% |
| 2023 Q1 | 384.31 Million CNY | -13.58% |
| 2023 Q2 | 319.04 Million CNY | -16.98% |
| 2022 Q1 | 570.71 Million CNY | 19.01% |
| 2022 FY | 1.82 Billion CNY | 29.97% |
| 2022 Q3 | 403.95 Million CNY | 0.36% |
| 2022 Q2 | 402.49 Million CNY | -29.48% |
| 2022 Q4 | 444.69 Million CNY | 10.08% |
| 2021 Q3 | 321.86 Million CNY | -0.75% |
| 2021 Q2 | 324.3 Million CNY | 17.51% |
| 2021 FY | 1.4 Billion CNY | 24.78% |
| 2021 Q1 | 275.98 Million CNY | -23.43% |
| 2021 Q4 | 479.54 Million CNY | 48.99% |
| 2020 Q2 | 231.71 Million CNY | 56.39% |
| 2020 Q4 | 360.43 Million CNY | -5.9% |
| 2020 FY | 1.12 Billion CNY | 16.02% |
| 2020 Q1 | 148.16 Million CNY | -56.12% |
| 2020 Q3 | 383.02 Million CNY | 65.3% |
| 2019 Q2 | 234.38 Million CNY | 13.47% |
| 2019 Q4 | 337.64 Million CNY | 78.08% |
| 2019 FY | 968.2 Million CNY | 41.09% |
| 2019 Q3 | 189.6 Million CNY | -19.1% |
| 2019 Q1 | 206.56 Million CNY | -11.19% |
| 2018 Q1 | 143.59 Million CNY | -9.32% |
| 2018 FY | 686.23 Million CNY | 40.45% |
| 2018 Q4 | 232.59 Million CNY | 61.53% |
| 2018 Q3 | 143.99 Million CNY | -13.28% |
| 2018 Q2 | 166.04 Million CNY | 15.63% |
| 2017 Q1 | 92.47 Million CNY | -23.22% |
| 2017 Q2 | 118.53 Million CNY | 28.19% |
| 2017 Q3 | 119.2 Million CNY | 0.56% |
| 2017 Q4 | 158.36 Million CNY | 32.85% |
| 2017 FY | 488.58 Million CNY | 32.37% |
| 2016 Q3 | 79.81 Million CNY | -16.34% |
| 2016 Q1 | 73.42 Million CNY | 0.0% |
| 2016 Q2 | 95.4 Million CNY | 29.94% |
| 2016 Q4 | 120.43 Million CNY | 50.89% |
| 2016 FY | 369.09 Million CNY | 33.53% |
| 2015 Q1 | 56.4 Million CNY | 0.0% |
| 2015 FY | 276.42 Million CNY | 31.45% |
| 2014 FY | 210.29 Million CNY | 36.38% |
| 2013 FY | 154.19 Million CNY | 109.39% |
| 2012 FY | 73.64 Million CNY | 0.0% |